C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1994
12/22/1994	CA2161811A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
12/22/1994	CA2125761A1 Ubiquitin carrier enzyme e2-f1, purification, production and use
12/21/1994	EP0629703A2 Monoclonal antibodies to Fc receptors for immunoglobulin G on human mono-nuclear phagocytes, bifunctional antibodies, target specific effector cells, targeted macrophages, and innunoassays
12/21/1994	EP0629700A2 Vector and mammalian cell line having improved productivity
12/21/1994	EP0629696A1 Recombinant DNA-derived bordetella toxin subunit analogs
12/21/1994	EP0629695A1 Novel Aminopeptidase from Streptomyces
12/21/1994	EP0629636A1 Lipopeptides from actinoplanes sp. endowed with pharmacological activity, process for their preparation and their use
12/21/1994	EP0629350A1 Milk protein hydrolysates
12/21/1994	EP0629240A1 Altered antibodies, products and processes relating thereto
12/21/1994	EP0629239A1 INSECTICIDAL TOXINS FROM THE PARASITIC WASP $i(BRACON HEBETOR)
12/21/1994	EP0629238A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
12/21/1994	EP0629206A1 Immunological detection of organophosphates
12/21/1994	EP0629132A1 PURIFIED VACUOLATING TOXIN FROM $i(HELICOBACTER) PYLORI AND METHODS TO USE SAME
12/21/1994	EP0629131A1 ANTIGENS PROTECTIVE AGAINST $i(ECHINOCOCCUS GRANULOSUS) INFECTION AND VACCINES CONTAINING SUCH ANTIGENS
12/21/1994	EP0551275B1 Non-a non-b sequences
12/21/1994	EP0494193B1 Diagnosis for malignant hyperthermia
12/21/1994	EP0217814B2 A process for producing human growth hormone
12/21/1994	CN1096541A Recombination of human macrophage colony stimulating factor by domestic silkworm gene engineering
12/20/1994	US5374618 Calcitonin peptides, and gene related pharmaceutical compositions
12/20/1994	US5374555 Protease catalyzed treatments of lignocellulose materials
12/20/1994	US5374550 Thyroid-derived chondrocyte-stimulating factor
12/20/1994	US5374540 Chitinase-producing bacteria and plants
12/20/1994	US5374531 Immunoassay for determination of cells
12/20/1994	US5374529 Methods of and compositions for diagnosis, monitoring and treating the early stages of osteoarthritis
12/20/1994	US5374518 Monoclonal antibody for differentiating HIV-2 from HIM-1 seropositive individuals
12/20/1994	US5374431 Polypeptide chains having helical structure in aqueous environments containing crosslinkable surface adherable amino acids; form insoluble matrix for adhering cells
12/17/1994	CA2125793A1 Organic compounds
12/14/1994	EP0628820A2 Diagnosis and monitoring of colon cancer patients by measurement of NCA 50/90 in blood
12/14/1994	EP0628639A1 Reconstituted human antibody against human interleukin 6 receptor
12/14/1994	EP0628631A1 A phosphatidylethanolamine binding protein derived from a human glioblastoma cell line and DNA encoding it
12/14/1994	EP0628629A1 Process of production and extraction of thermostable superoxyde dismutases from a culture of photosynthetic micro-organisms
12/14/1994	EP0628572A2 DNA originating in non-A non-B hepatitis virus gene and constituting polypeptide
12/14/1994	EP0628084A1 Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus
12/14/1994	EP0628079A1 Hepatitis c virus peptides
12/14/1994	EP0628078A1 Multivalent single chain antibodies
12/14/1994	EP0628077A1 Humanised antibodies directed against a33 antigen
12/14/1994	EP0628076A1 PRODUCTION OF MONOCLONAL RECOMBINANT ANTIBODIES WITHOUT THE USE OF HYBRIDOMAS BY $i(IN VITRO) SPLEEN FRAGMENT CULTURE COMBINED WITH ISOTHERMAL SELF-SUSTAINED SEQUENCE REPLICATION OF RNA
12/14/1994	EP0628075A1 Endo-1,4-beta-d-glucanase
12/14/1994	EP0628055A1 Modified tcf
12/14/1994	EP0628054A1 Car receptors and related molecules and methods
12/14/1994	EP0628053A1 Hepatitis e virus peptide antigens and antibodies
12/14/1994	EP0627940A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
12/14/1994	EP0627936A1 Feline infectious peritonitis vaccine and method of preparation
12/14/1994	EP0627934A1 Early antigen for autoimmune diabetes
12/14/1994	EP0627932A1 Novel antibody construct
12/14/1994	EP0627923A1 Therapeutic domains of von willebrand factor
12/14/1994	EP0471030B1 Glycoprotein hormone receptor molecules
12/14/1994	EP0380607B1 Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
12/14/1994	EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition
12/14/1994	CN1096223A Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases
12/14/1994	CN1026994C Kluyveromyces as a host strain
12/13/1994	US5373090 Aprotinin analogues and a process for the production thereof
12/13/1994	US5372933 Antibody-polypeptide immunocomplex
12/13/1994	CA2035389C Bacteriocin peptide
12/09/1994	CA2125008A1 Peptide and dnas encoding it
12/08/1994	WO1994028413A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
12/08/1994	WO1994028391A1 Ligands for flt3 receptors
12/08/1994	WO1994028170A1 Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path
12/08/1994	WO1994028161A1 Antibodies specific for dcc gene product
12/08/1994	WO1994028160A1 Monoclonal antibody, process for producing the same, and use thereof
12/08/1994	WO1994028159A1 Reconstructed human antibody against human interleukin-6
12/08/1994	WO1994028158A1 Antimucoglycoprotein monoclonal antibody
12/08/1994	WO1994028157A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein
12/08/1994	WO1994028151A1 Gene therapy for haemophilia
12/08/1994	WO1994028145A2 Expression of urokinase plasminogen activator inhibitors
12/08/1994	WO1994028144A1 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
12/08/1994	WO1994028138A1 Multiple sclerosis virus
12/08/1994	WO1994028137A1 Regulator of contact-mediated hemolysin
12/08/1994	WO1994028134A1 Lymphocyte chemoattractant factor and uses thereof
12/08/1994	WO1994028132A2 Opioid receptors: compositions and methods
12/08/1994	WO1994028127A1 Cancer treatment
12/08/1994	WO1994028125A2 Dna encoding prostaglandin receptor ep1
12/08/1994	WO1994028116A1 Nucleic acid encoding amp-activated protein kinase
12/08/1994	WO1994028027A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
12/08/1994	WO1994028026A1 Genetically engineered immunoglobulins
12/08/1994	WO1994028025A1 Methods and compositions for inhibiting cd14 mediated cell activation
12/08/1994	WO1994028023A1 Cell surface protein expressed on human cortical thymocyte and their use
12/08/1994	WO1994028019A1 Human calcium sensor
12/08/1994	WO1994028016A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
12/08/1994	WO1994027637A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
12/08/1994	WO1994027435A1 Genetic immunization with cationic lipids
12/08/1994	WO1994027428A1 Post-transcriptional gene regulation by trace minerals
12/08/1994	WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
12/08/1994	WO1994024283A3 A mammalian guanine nucleotide binding protein with an adp-rybosylation factor domain
12/08/1994	WO1994024163A3 Bispecific antigen-binding molecules
12/08/1994	WO1994004675A3 Dna sequence encoding a novel member of the steroid and thyroid hormone receptor family
12/08/1994	DE4403057C1 Platelet-stabilising factor IX fragments, the preparation thereof and pharmaceutical compositions containing them
12/08/1994	CA2698716A1 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
12/08/1994	CA2164428A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
12/08/1994	CA2163549A1 Process for screening substances having a modulating effect on any interleukin-5 receptor mediated cellular signal transmission pathway
12/08/1994	CA2163438A1 Regulator of contact-mediated hemolysin
12/08/1994	CA2163422A1 Antibodies specific for dcc gene product
12/08/1994	CA2163350A1 Opioid receptors: compositions and methods
12/08/1994	CA2163125A1 Genetically engineered immunoglobulins
12/08/1994	CA2163013A1 Human calcium sensor
12/08/1994	CA2162855A1 Expression of urokinase plasminogen activator inhibitors
12/08/1994	CA2162271A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein
12/08/1994	CA2161979A1 Cloning, expression and uses of dorsalin-1
12/08/1994	CA2141540A1 Monoclonal antibody, method for preparing the same and use of the same
12/07/1994	EP0627487A2 Ligands for FLT3 receptors

1 ... 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 ... 1125